 |
|
|
ANTICANCER DRUG DEVELOPMENT
| |
| | |
|
|
To order this title, and for more information, click here
Edited By
Bruce Baguley, The University of Auckland, New Zealand
David Kerr, University of Oxford, United Kingdom
Reviews
?Paul Loadman, University of Bradford, UK for BRITISH JOURNAL OF CANCER (2002)
"..this is a really extensive and comprehensive book on the drug development process. ...There is very little overlap between chapters
and all are written by experts in the field. Hundreds of useful references are included for those wanting to go further. ...Very good
value...and essential reading for both the scientist and Ph.D. student. Definately one for the library to stock."
—P. Parsons, Queensland Institute of Medical Research for CANCER FORUM (2002)
"Well-referenced and indexed...this text would be a useful addition to the clinic, research laboratory and institution library."
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company